Deutsche Bank AG Raises Position in National Research Co. (NASDAQ:NRC)

Deutsche Bank AG increased its holdings in National Research Co. (NASDAQ:NRC) by 37.7% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,431 shares of the company’s stock after buying an additional 5,048 shares during the period. Deutsche Bank AG owned 0.08% of National Research worth $325,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in NRC. PNC Financial Services Group Inc. grew its stake in shares of National Research by 2,250.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company’s stock worth $27,000 after purchasing an additional 1,463 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of National Research by 376.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock valued at $44,000 after purchasing an additional 1,981 shares during the last quarter. KLP Kapitalforvaltning AS bought a new position in National Research in the 4th quarter valued at approximately $50,000. Signaturefd LLC lifted its position in National Research by 613.3% in the 4th quarter. Signaturefd LLC now owns 4,173 shares of the company’s stock valued at $74,000 after acquiring an additional 3,588 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in National Research by 219.3% in the 4th quarter. Quadrant Capital Group LLC now owns 5,006 shares of the company’s stock valued at $88,000 after acquiring an additional 3,438 shares in the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Price Performance

Shares of NRC opened at $13.70 on Friday. The firm has a market cap of $312.15 million, a PE ratio of 13.05 and a beta of 0.34. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The firm has a fifty day simple moving average of $12.42 and a two-hundred day simple moving average of $15.50. National Research Co. has a 1-year low of $9.76 and a 1-year high of $28.76.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Monday, April 28th. The company reported $0.25 EPS for the quarter. The firm had revenue of $33.55 million during the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 3.50%. The ex-dividend date is Friday, June 27th. National Research’s dividend payout ratio is currently 46.60%.

Insider Buying and Selling

In related news, major shareholder Patrick E. Beans acquired 2,500 shares of the company’s stock in a transaction on Monday, May 12th. The stock was acquired at an average price of $13.59 per share, with a total value of $33,975.00. Following the acquisition, the insider now directly owns 35,003 shares of the company’s stock, valued at approximately $475,690.77. This trade represents a 7.69% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 8.10% of the stock is currently owned by insiders.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.